Research Programmes / Core Facilities

Mouse Mutant Core Facility
<p>Vilaseca</p>
Marta Vilaseca
Annie Rodolosse
Nick Berrow
Camille Stephan-otto Attolini

Research Programmes

  • Cell and Developmental Biology
    More about Cell and Developmental Biology
  • Structural and Computational Biology
    More about Structural and Computational Biology
  • Molecular Medicine
    More about Molecular Medicine
  • Chemistry and Molecular Pharmacology
    More about Chemistry and Molecular Pharmacology
  • Oncology
    More about Oncology

Core Facilities & Services

Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.

Interdisciplinary initiatives

IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine

Selected IRB Barcelona publications

Georgieva MV, Yahya G, Codó L, Ortiz R, Teixidó L, Claros J, Jara R, Jara M, Iborra A, Gelpí JL, Gallego C, Orozco M and Aldea M.
Nat Methods, 12 (10), 955-8 (2015)
Pavlovic M, Arnal-Estapé A, Rojo F, Bellmunt A, Tarragona M, Guiu M, Planet E, Garcia-Albéniz X, Morales M, Urosevic J, Gawrzak S, Rovira A, Prat A, Nonell L, Lluch A, Jean-Mairet J, Coleman R, Albanell J and Gomis RR.
J Natl Cancer I, 107 (12), (2015)
Marjanović M, Sánchez-Huertas C, Terré B, Gómez R, Scheel JF, Pacheco S, Knobel PA, Martínez-Marchal A, Aivio S, Palenzuela L, Wolfrum U, McKinnon PJ, Suja JA, Roig I, Costanzo V, Lüders J and Stracker TH.
Nat Commun, 6 7676 (2015)
Kessler R, Tisserand J, Font-Burgada J, Reina O, Coch L, Attolini CS, Garcia-Bassets I and Azorín F.
Nat Commun, 6 7049 (2015)
<p>Nat Gen 2015</p>
Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M, Palomo-Ponce S, Tauriello DV, Byrom D, Cortina C, Morral C, Barceló C, Tosi S, Riera A, Attolini CS, Rossell D, Sancho E and Batlle E.
Nat Genet, 47 (4), 320-329 (2015)
Prades R, Oller-Salvia B, Schwarzmaier SM, Selva J, Moros M, Balbi M, Grazú V, de La Fuente JM, Egea G, Plesnila N, Teixidó M and Giralt E.
Angew Chem Int Edit, 54 (13), 3967-72 (2015)
Sala D, Ivanova S, Plana N, Ribas V, Duran J, Bach D, Turkseven S, Laville M, Vidal H, Karczewska-Kupczewska M, Kowalska I, Straczkowski M, Testar X, Palacín M, Sandri M, Serrano AL and Zorzano A.
J Clin Invest, 124 (5), 1914-27 (2014)
<p>Nature Cell 16 8</p>
Lecland N and Lüders J.
Nat Cell Biol, 16 (8), 770-8 (2014)
<p>Natcom</p>
Fenwick RB, Orellana L, Esteban-Martín S, Orozco M and Salvatella X.
Nat Commun, 5 4070 (2014)
<p>Nature Cell 16 7</p>
Whissell G, Montagni E, Martinelli P, Hernando-Momblona X, Sevillano M, Jung P, Cortina C, Calon A, Abuli A, Castells A, Castellvi-Bel S, Nacht AS, Sancho E, Stephan-Otto Attolini C, Vicent GP, Real FX and Batlle E.
Nat Cell Biol, 16 (7), 695-707 (2014)
<p>Nature Cell 16 7</p>
Urosevic J, Garcia-Albéniz X, Planet E, Real S, Céspedes MV, Guiu M, Fernandez E, Bellmunt A, Gawrzak S, Pavlovic M, Mangues R, Dolado I, Barriga FM, Nadal C, Kemeny N, Batlle E, Nebreda AR and Gomis RR.
Nat Cell Biol, 16 (7), 685-94 (2014)

News

<p>In the picture, precursor cells of fly wing tissue, labelled for various proteins. This fly model has been used to perform experiments addressing the relationship between chromosome instability, aneuploidy, and tumorigenesis (Lara Barrio, IRB Barcelona)</p>
9 Feb 2016

A recent analysis of 43,205 human tumours unveiled that 68% of solid tumours are aneuploid, that is to say, they have an altered number of chromosomes.

<p>The compound Cp28 (orange) binds to the EGF protein (green), a target in cancer. This interaction prevents EGF from binding to its receptor EGFR.</p>
3 Feb 2016

Advances in new treatments for diseases, including cancer, come about from innovative research with therapeutic potential.

2 Feb 2016

This morning in Madrid, Joan Guinovart, director of the Institute for Research in Biomedicine (IRB Barcelona), has been presented with a second

17 Dec 2015

The colon cancer research project undertaken by Dr.

Events

19 Feb
Sala Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Andrés López-Contreras, PhD, Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark
26 Feb
Felix Serratosa, Parc Científic de Barcelona
Speaker:
Fernando Martin-Belmonte, PhD - Dept. Development and Regeneration Centro de Biología Molecular Severo Ochoa (CSIC-UAM) Madrid , Spain
03 Mar
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Diego Pasini, PhD. Department of Experimental Oncology, European Institute of Oncology. Milano (Italy)